Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (72 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

Bullboard (TSXV:TLT)

View:
Comment by toade1313on Sep 04, 2024 4:50pm

RE:RE:RE:RE:RE:New Proactive Video

All pitchers used.  1st base coach warming up in the bullpen. Batboy catching his tosses. Out of respect for those that know much more than I, no guesses for BTD from me. 
Comment by Kayz88on Sep 04, 2024 4:41pm

RE:RE:RE:RE:New Proactive Video

Lol agreed. We are already in OT 27th inning, audience is exhausted, food and drinks are running out. 
Comment by Kayz88on Sep 04, 2024 4:40pm

RE:RE:RE:General question for the board

I would conservatively put the company at 300m - 500m? So share price wise that's more than $1.50 but less than $2.50. My opinion only cause BTD doesn't mean approval, it's just validation
Comment by N0taP00pon Sep 04, 2024 4:39pm

RE:RE:RE:General question for the board

BlueFranky: This is what I had guesstimated a few weeks ago.  IBRX has FDA approval and insurance companies have recently incorporated the treatment into their coverage plans.  The ...more  
Comment by BlueFrankyon Sep 04, 2024 4:28pm

RE:RE:General question for the board

Minimum projected share price for BTD only.. is what I'm after at this moment.. many thanks!
Comment by chry200030on Sep 04, 2024 4:06pm

RE:General question for the board

The share price would make you say .... I wish I had bought yesterday.... For some it's .50, for some it's 3.00. I'm  in it for a lot higher.
Post by BlueFrankyon Sep 04, 2024 3:53pm

General question for the board

Assuming we get BTD and fairly soon, what do you all suppose the impact could be on the share price, from conservative to realistic, given everything we currently know about the science, Nmibc ...more  
Comment by Gooseybearon Sep 04, 2024 3:16pm

RE:RE:RE:New Proactive Video

My family members have used Acyclovir for years to combat cold sores caused by herpes simplex 2 which is from the chicken pox virus. There are millions of people who have had the chicken pox and it is ...more  
Comment by toade1313on Sep 04, 2024 2:35pm

RE:RE:RE:New Proactive Video

EARLY INNINGS?????   Some of us have been in this for many Decades. Game in a "Rain Delay" and tornado approaching. A small umbrella aint gonna help that much. 
Comment by CancerSlayeron Sep 04, 2024 12:27pm

RE:RE:New Proactive Video

Agree...we are in the early innings. Although Ruvidar is still in the research/preclinical stages for this HSV-1 indication, the in vitro testing was not a "solo" performance study, but was ...more  
Post by reconsideron Sep 04, 2024 11:21am

FDA: BCG-Unresponsive. Guidance for Industry

BCG-Unresponsive Nonmuscle Invasive Bladder Cancer: Developing Drug and Biological Products for Treatment. Guidance for Industry. Date: August 2024. https://www.fda.gov/media/101468/download ...more  
Comment by wildbird1on Sep 04, 2024 6:00am

RE:Food for thought...

Silly me, I forgot to tell you something very important... '' I LOVE MY TLT SHARES'' 
Comment by N0taP00pon Sep 03, 2024 9:48pm

RE:RE:New Proactive Video

It feels like these petri dish type NRs are  generally stacked closer to PP phases in the hopes of attracting new buyers.  It's a guess...and probably what they need to do tactically ...more  
Post by Betteryear2on Sep 03, 2024 8:43pm

Ruvidar(TM) Proven More Effective Than Acyclovir V.TLT

The latest research now demonstrates that Ruvidar TM is more potent than Acyclovir, the gold-standard anti-herpetic treatment, in destroying an ongoing HSV-1 infection. Ruvidar(TM) Proven ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250